DRAEGERWERK AG (DRW8.DE) Fundamental Analysis & Valuation

FRA:DRW8 • DE0005550602

71.2 EUR
-0.4 (-0.56%)
Last: Mar 6, 2026, 03:20 PM

This DRW8.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall DRW8 gets a fundamental rating of 5 out of 10. We evaluated DRW8 against 63 industry peers in the Health Care Equipment & Supplies industry. DRW8 has only an average score on both its financial health and profitability. DRW8 may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

4

1. DRW8.DE Profitability Analysis

1.1 Basic Checks

  • In the past year DRW8 was profitable.
  • In the past year DRW8 had a positive cash flow from operations.
  • Of the past 5 years DRW8 4 years were profitable.
  • DRW8 had a positive operating cash flow in 4 of the past 5 years.
DRW8.DE Yearly Net Income VS EBIT VS OCF VS FCFDRW8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • DRW8 has a Return On Assets of 3.99%. This is in the better half of the industry: DRW8 outperforms 61.90% of its industry peers.
  • DRW8's Return On Equity of 8.02% is in line compared to the rest of the industry. DRW8 outperforms 55.56% of its industry peers.
  • The Return On Invested Capital of DRW8 (7.67%) is better than 61.90% of its industry peers.
Industry RankSector Rank
ROA 3.99%
ROE 8.02%
ROIC 7.67%
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
DRW8.DE Yearly ROA, ROE, ROICDRW8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • DRW8's Profit Margin of 3.54% is in line compared to the rest of the industry. DRW8 outperforms 44.44% of its industry peers.
  • DRW8's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 6.02%, DRW8 is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
  • DRW8's Operating Margin has improved in the last couple of years.
  • DRW8 has a Gross Margin of 45.35%. This is in the lower half of the industry: DRW8 underperforms 68.25% of its industry peers.
  • DRW8's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.02%
PM (TTM) 3.54%
GM 45.35%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
DRW8.DE Yearly Profit, Operating, Gross MarginsDRW8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

6

2. DRW8.DE Health Analysis

2.1 Basic Checks

  • DRW8 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for DRW8 has been reduced compared to 1 year ago.
  • DRW8 has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, DRW8 has an improved debt to assets ratio.
DRW8.DE Yearly Shares OutstandingDRW8.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
DRW8.DE Yearly Total Debt VS Total AssetsDRW8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.75 indicates that DRW8 is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • DRW8 has a Altman-Z score of 2.75. This is comparable to the rest of the industry: DRW8 outperforms 53.97% of its industry peers.
  • The Debt to FCF ratio of DRW8 is 2.16, which is a good value as it means it would take DRW8, 2.16 years of fcf income to pay off all of its debts.
  • DRW8 has a better Debt to FCF ratio (2.16) than 79.37% of its industry peers.
  • A Debt/Equity ratio of 0.10 indicates that DRW8 is not too dependend on debt financing.
  • DRW8 has a Debt to Equity ratio of 0.10. This is in the better half of the industry: DRW8 outperforms 79.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 2.16
Altman-Z 2.75
ROIC/WACC1.13
WACC6.81%
DRW8.DE Yearly LT Debt VS Equity VS FCFDRW8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • DRW8 has a Current Ratio of 1.76. This is a normal value and indicates that DRW8 is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.76, DRW8 is doing good in the industry, outperforming 61.90% of the companies in the same industry.
  • A Quick Ratio of 1.03 indicates that DRW8 should not have too much problems paying its short term obligations.
  • DRW8 has a Quick ratio (1.03) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.03
DRW8.DE Yearly Current Assets VS Current LiabilitesDRW8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. DRW8.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.68% over the past year.
  • The Earnings Per Share has been growing by 36.42% on average over the past years. This is a very strong growth
  • The Revenue has been growing slightly by 2.14% in the past year.
  • Measured over the past years, DRW8 shows a small growth in Revenue. The Revenue has been growing by 3.92% on average per year.
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%

3.2 Future

  • Based on estimates for the next years, DRW8 will show a small growth in Earnings Per Share. The EPS will grow by 7.93% on average per year.
  • The Revenue is expected to grow by 2.85% on average over the next years.
EPS Next Y6.71%
EPS Next 2Y10.8%
EPS Next 3Y11.15%
EPS Next 5Y7.93%
Revenue Next Year2.84%
Revenue Next 2Y3.75%
Revenue Next 3Y3.84%
Revenue Next 5Y2.85%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DRW8.DE Yearly Revenue VS EstimatesDRW8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
DRW8.DE Yearly EPS VS EstimatesDRW8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10

7

4. DRW8.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • DRW8 is valuated reasonably with a Price/Earnings ratio of 11.04.
  • 100.00% of the companies in the same industry are more expensive than DRW8, based on the Price/Earnings ratio.
  • DRW8's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.69.
  • With a Price/Forward Earnings ratio of 9.76, the valuation of DRW8 can be described as very reasonable.
  • 95.24% of the companies in the same industry are more expensive than DRW8, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 24.79. DRW8 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.04
Fwd PE 9.76
DRW8.DE Price Earnings VS Forward Price EarningsDRW8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 95.24% of the companies in the same industry are more expensive than DRW8, based on the Enterprise Value to EBITDA ratio.
  • DRW8's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DRW8 is cheaper than 95.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.76
EV/EBITDA 3.9
DRW8.DE Per share dataDRW8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • DRW8's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.65
PEG (5Y)0.3
EPS Next 2Y10.8%
EPS Next 3Y11.15%

6

5. DRW8.DE Dividend Analysis

5.1 Amount

  • DRW8 has a Yearly Dividend Yield of 2.70%.
  • Compared to an average industry Dividend Yield of 1.06, DRW8 pays a better dividend. On top of this DRW8 pays more dividend than 87.30% of the companies listed in the same industry.
  • DRW8's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.7%

5.2 History

  • On average, the dividend of DRW8 grows each year by 51.02%, which is quite nice.
Dividend Growth(5Y)51.02%
Div Incr Years2
Div Non Decr Years4
DRW8.DE Yearly Dividends per shareDRW8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 31.13% of the earnings are spent on dividend by DRW8. This is a low number and sustainable payout ratio.
  • DRW8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP31.13%
EPS Next 2Y10.8%
EPS Next 3Y11.15%
DRW8.DE Yearly Income VS Free CF VS DividendDRW8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M
DRW8.DE Dividend Payout.DRW8.DE Dividend Payout, showing the Payout Ratio.DRW8.DE Dividend Payout.PayoutRetained Earnings

DRW8.DE Fundamentals: All Metrics, Ratios and Statistics

DRAEGERWERK AG

FRA:DRW8 (3/6/2026, 3:20:58 PM)

71.2

-0.4 (-0.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29
Earnings (Next)03-24
Inst Owners10.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.34B
Revenue(TTM)3.42B
Net Income(TTM)120.88M
Analysts80
Price Target86.55 (21.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.7%
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP31.13%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.8%
PT rev (3m)4.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 11.04
Fwd PE 9.76
P/S 0.39
P/FCF 9.76
P/OCF 6.58
P/B 0.89
P/tB 1.14
EV/EBITDA 3.9
EPS(TTM)6.45
EY9.06%
EPS(NY)7.3
Fwd EY10.25%
FCF(TTM)7.29
FCFY10.25%
OCF(TTM)10.82
OCFY15.19%
SpS182.27
BVpS80.37
TBVpS62.21
PEG (NY)1.65
PEG (5Y)0.3
Graham Number108
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 8.02%
ROCE 10.2%
ROIC 7.67%
ROICexc 8.64%
ROICexgc 10.67%
OM 6.02%
PM (TTM) 3.54%
GM 45.35%
FCFM 4%
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score7
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 2.16
Debt/EBITDA 0.44
Cap/Depr 44.92%
Cap/Sales 1.93%
Interest Coverage 11.48
Cash Conversion 57.51%
Profit Quality 113.22%
Current Ratio 1.76
Quick Ratio 1.03
Altman-Z 2.75
F-Score7
WACC6.81%
ROIC/WACC1.13
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
EPS Next Y6.71%
EPS Next 2Y10.8%
EPS Next 3Y11.15%
EPS Next 5Y7.93%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
Revenue Next Year2.84%
Revenue Next 2Y3.75%
Revenue Next 3Y3.84%
Revenue Next 5Y2.85%
EBIT growth 1Y12.74%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year93.29%
EBIT Next 3Y28.8%
EBIT Next 5Y15.91%
FCF growth 1Y20.52%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y11.8%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%

DRAEGERWERK AG / DRW8.DE FAQ

Can you provide the ChartMill fundamental rating for DRAEGERWERK AG?

ChartMill assigns a fundamental rating of 5 / 10 to DRW8.DE.


What is the valuation status of DRAEGERWERK AG (DRW8.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to DRAEGERWERK AG (DRW8.DE). This can be considered as Undervalued.


What is the profitability of DRW8 stock?

DRAEGERWERK AG (DRW8.DE) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for DRW8 stock?

The Price/Earnings (PE) ratio for DRAEGERWERK AG (DRW8.DE) is 11.04 and the Price/Book (PB) ratio is 0.89.


What is the expected EPS growth for DRAEGERWERK AG (DRW8.DE) stock?

The Earnings per Share (EPS) of DRAEGERWERK AG (DRW8.DE) is expected to grow by 6.71% in the next year.